Clinical Trials
All Clinical Trials - Page 27 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT04734730Phase 2Recruiting
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
Gonadorelin
- NCT05005741Phase 4Unknown
The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.
Dulaglutide
- NCT04878393N/ACompleted
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical Practice
Semaglutide
- NCT05414279N/ACompleted
Validation of Capillary Serum Sodium Levels
Desmopressin
- NCT04738799N/ACompleted
The Impact of Food Order on Glycemic Excursions in Type 2 Diabetes Assessed by Continuous Glucose Monitoring
Ghrp-6
- NCT04909333N/ACompleted
Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
Exenatide
- NCT04771273Phase 2Completed
A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)
Survodutide
- NCT04649580N/ACompleted
United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting
Lanreotide
- NCT04997317Phase 1/Phase 2Recruiting
Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide
Octreotide
- NCT04847557Phase 3Completed
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
Tirzepatide
- NCT04809220Phase 3Completed
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
Dulaglutide
- NCT05086614Phase 3Recruiting
Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal Cancer
Thymosin-Alpha-1
- NCT06867250N/ACompleted
Peri-implant Vitamin D and Cathelicidin (LL-37) Levels
Ll-37
- NCT05360537Phase 4Completed
Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients
Liraglutide
- NCT04657003Phase 3Completed
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
Tirzepatide
- NCT04660643Phase 3Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
Tirzepatide
- NCT04657016Phase 3Completed
A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
Tirzepatide
- NCT04680767Phase 1Completed
A Study of LY3502970 in Healthy Male Participants
Orforglipron
- NCT04639414Phase 4Completed
Combined Active Treatment in Type 2 Diabetes With NASH
Semaglutide
- NCT04702516Phase 1/Phase 2Unknown
The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture
Semaglutide
- NCT04683237Phase 2/Phase 3Withdrawn
Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia
Liraglutide
- NCT04356664Phase 2/Phase 3Recruiting
Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis
Gonadorelin
- NCT03902951Phase 2Active Not Recruiting
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
Gonadorelin
- NCT04788511Phase 3Completed
Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity
Semaglutide
- NCT04667377Phase 2Completed
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight
Survodutide
- NCT04804267Phase 3Unknown
Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation
Linaclotide
- NCT04775082Phase 3Active Not Recruiting
SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
Liraglutide
- NCT04773977Phase 1Completed
Clinical Study of IBI362 in Healthy Chinese Male Subjects
Mazdutide
- NCT04750460Phase 3Completed
Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
Teriparatide
- NCT03708926Phase 2Withdrawn
Effect of Abaloparatide on Lumbar Disc Degeneration
Abaloparatide
- NCT04861493N/ACompleted
Cathelicidin LL-37 Levels in the GCF and the Saliva of Smokers and Non-smokers With Stage III,IV Periodontitis
Ll-37
- NCT05041673N/AUnknown
Anti-diabetic Drugs and Fatty Liver Management
Liraglutide
- NCT04216589Phase 2Completed
Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)
Semaglutide
- NCT05140512Phase 1Completed
Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®
Gonadorelin
- NCT05557604Phase 2Recruiting
Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer
Gonadorelin
- NCT04779697Phase 1Completed
GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight
Semaglutide
- NCT04997252N/AUnknown
An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer
Gonadorelin
- NCT04881110Phase 4Completed
Liraglutide and Peripheral Artery Disease
Liraglutide
- NCT04467983Phase 4Active Not Recruiting
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
Abaloparatide
- NCT04520490Phase 3Active Not Recruiting
Brain Activation and Satiety in Children 2
Exenatide
- NCT04572165N/ACompleted
Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data
Semaglutide
- NCT05971836N/ACompleted
The Molecular Basis of Inherited Reproductive Disorders
Kisspeptin
- NCT05360147Phase 3Completed
Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT04529278Phase 2Unknown
Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
Liraglutide
- NCT04707469Phase 3Completed
Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes
Semaglutide
- NCT04551495Phase 2Unknown
Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE)
Gonadorelin
- NCT04465396Phase 1Completed
A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants
Teduglutide
- NCT04428008Phase 2Completed
Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients
Thymosin-Alpha-1
- NCT04969627Phase 4Completed
Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia.
Exenatide
- NCT04973969N/AUnknown
Follicular Challenge Test to Predict Response to GnRH Agonist Triggering
Gonadorelin